Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

154 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)

NCT04626479

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of California at San Francisco ( Site 1008) San Francisco, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 1011) New Haven, Connecticut, United States
  • University of Chicago ( Site 1013) Chicago, Illinois, United States
  • University of Iowa ( Site 1012) Iowa City, Iowa, United States
View all 55 locations
View Trial Details
Completed

A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)

NCT04489771

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Georgetown University Medical Center ( Site 0002) Washington D.C., District of Columbia, United States
  • Univ of Miami- Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States
  • Norton Cancer Institute - St. Matthews ( Site 0025) Louisville, Kentucky, United States
  • Weinberg Cancer Institute at Franklin Square ( Site 0007) Baltimore, Maryland, United States
View all 48 locations
View Trial Details
Completed

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

NCT04544748

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations
  • SAHI "Republican Clinical Oncological Dispensary of the Ministry of Health of the Republic of Tatarstan" Kazan', Russia
  • FSBI "N.N. Blokhin National Medical Research Center of Oncology"of the Ministry of Health of the Russian Federation Moscow, Russia
  • FSBI "Russian Scientific Center of Roentgenoradiology" of the Ministry of Health of the Russian Federation Moscow, Russia
  • FSAEI HE "I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of Russian Federation Moscow, Russia
View Trial Details
Completed

A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

NCT04846920

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Beth Israel Deaconess Medical Center ( Site 1002) Boston, Massachusetts, United States
  • University of Michigan ( Site 1006) Ann Arbor, Michigan, United States
  • Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center-Genitourinary Medical Oncology ( Site 1007) Houston, Texas, United States
View Trial Details
Completed

Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma

NCT00720941

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Novartis Investigative Site Huntsville, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Beverly Hills, California, United States
View all 227 locations
View Trial Details
Completed

Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma

NCT01147822

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Nanjing, Jiangsu, China
  • Novartis Investigative Site Hangzhou, Zhejiang, China
  • Novartis Investigative Site Beijing, China
View all 21 locations
View Trial Details

Related conditions